BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37577928)

  • 1. Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases.
    Rivas-Macho A; Romeo MV; Rackles E; Olabarria G; Falcon-Perez JM; Berganza-Granda J; Cortajarena AL; Goñi-de-Cerio F
    Expert Rev Mol Diagn; 2023; 23(10):875-884. PubMed ID: 37577928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting heat shock protein 90 for anti-cancer drug development.
    Aswad A; Liu T
    Adv Cancer Res; 2021; 152():179-204. PubMed ID: 34353437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.
    Patel HJ; Modi S; Chiosis G; Taldone T
    Expert Opin Drug Discov; 2011 May; 6(5):559-587. PubMed ID: 22400044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ηypoxia-inducible factor-1α, von Hippel-Lindau protein, and heat shock protein expression in ophthalmic pterygium and normal conjunctiva.
    Pagoulatos D; Pharmakakis N; Lakoumentas J; Assimakopoulou M
    Mol Vis; 2014; 20():441-57. PubMed ID: 24715760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.
    Samarasinghe B; Wales CT; Taylor FR; Jacobs AT
    Biochem Pharmacol; 2014 Feb; 87(3):445-55. PubMed ID: 24291777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases.
    Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A
    Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzo(a)pyrene regulates chaperone-mediated autophagy via heat shock protein 90.
    Su M; Zhou S; Li J; Lin N; Chi T; Zhang M; Lv X; Hu Y; Bai T; Chang F
    Toxicol Lett; 2023 Jul; 383():121-127. PubMed ID: 37390851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
    Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
    Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010.
    Messaoudi S; Peyrat JF; Brion JD; Alami M
    Expert Opin Ther Pat; 2011 Oct; 21(10):1501-42. PubMed ID: 21689065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of HSP90 molecular chaperones in hepatocellular carcinoma.
    Nouri-Vaskeh M; Alizadeh L; Hajiasgharzadeh K; Mokhtarzadeh A; Halimi M; Baradaran B
    J Cell Physiol; 2020 Dec; 235(12):9110-9120. PubMed ID: 32452023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous expression of heat shock protein 90kDa retards the cell cycle and impairs the heat shock response.
    Zhao C; Hashiguchi A; Kondoh K; Du W; Hata J; Yamada T
    Exp Cell Res; 2002 May; 275(2):200-14. PubMed ID: 11969290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma.
    Chatterjee M; Andrulis M; Stühmer T; Müller E; Hofmann C; Steinbrunn T; Heimberger T; Schraud H; Kressmann S; Einsele H; Bargou RC
    Haematologica; 2013 Jul; 98(7):1132-41. PubMed ID: 23065523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor.
    Liu F; Wang L; Yi S; Liu Q; Xu X; Su M
    Biomed Pharmacother; 2019 Dec; 120():109533. PubMed ID: 31634779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptor interactions with heat shock protein and immunophilin chaperones.
    Pratt WB; Toft DO
    Endocr Rev; 1997 Jun; 18(3):306-60. PubMed ID: 9183567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
    Kim T; Keum G; Pae AN
    Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes.
    Ali A; Bharadwaj S; O'Carroll R; Ovsenek N
    Mol Cell Biol; 1998 Sep; 18(9):4949-60. PubMed ID: 9710578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy.
    Ren X; Li T; Zhang W; Yang X
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.
    Blair LJ; Sabbagh JJ; Dickey CA
    Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heat shock protein 90 β isoform involved in immune response to bacteria challenge and heat shock from Miichthys miiuy.
    Wei T; Gao Y; Wang R; Xu T
    Fish Shellfish Immunol; 2013 Aug; 35(2):429-37. PubMed ID: 23684810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Hsp90 regulation.
    Prodromou C
    Biochem J; 2016 Aug; 473(16):2439-52. PubMed ID: 27515256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.